Specific immunotherapy suppresses IL-1β and IL-8 levels in nasal secretions: A possible explanation for the inhibition of inflammatory cell migration;Die spezifische immuntherapie reduziert IL-1β und IL-8-konzentrationen im nasensekret - Eine mogliche erklarung der hammung der einwanderung von entzundungszellen in die nasenschleimhaut

Oto-Rhino-Laryngologia Nova

Volumn 7, Issue 1, 1997, Pages 31-39

  Hauser, U ^a   Wagenmann, M ^a   Rudack, C ^a   Cromwell, O ^b   Ganzer, U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

Author keywords

Allergic rhinitis; Cytokines; Interleukin 1 ; Interleukin 6; Interleukin 8; Nasal secretions; Specific allergen immunotherapy

Indexed keywords

ALLERGOVIT; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; NOSE MUCOSA; NOSE SECRETION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030869361     PISSN: 10148221     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312889     Document Type: Article

References (31)

1. Norman PS: Immunotherapy for nasal allergy. J Allergy Clin Immunol 1988;81:992-996.
2. Malling HJ, Wecke B: Position paper: Immunotherapy. Allergy 1993;48(suppl 14):9-35.
3. Malling HJ: Review: Immunotherapy in Europe. Clin Exp Allergy 1994;24:515-521.
4. Kleine-Tebbe J, Kunkel G: Wirkungsweise der allergenspezifischen Immuntherapie bei inhalativen Allergien vom Soforttyp. Allergo J 1994;3:260-265.
5. Durham SR: New insights into the mechanisms of immunotherapy. Eur Arch Otorhinolaryngol 1995;252(suppl 1):64-67.
6. Fiebig H: Immunologische Aspekte der spezifischen Immuntherapie (Hyposensibilisierung). 1. Die Steuerung der IgE-Synthese. Allergo J 1995;4:336-339.
7. Fiebig H: Immunologische Aspekte der spezifischen Immuntherapie (Hyposensibilisierung). 2. Die Umorientierung der T-Helferzellreaktion. Allergo J 1995;4:377-382.
8. Bachert C, Schindlbeck G, Hauser U: Cellular infiltration in allergic late phase reaction of the nose: Immunohistochemical studies. Am J Rhinol 1991;5:227-233.
9. Hauser U, Bachert C, Prem B, Ganzer U: Zellwanderung und Symptomatik in der allergischen Spätphase-Reaktion der Nase. Allergologie 1992;15:172-192.
10. Bachert C, Ganzer U: Allergische Rhinitis: Zellen und Mediatoren in der Sofort- und Spätphase. 1. Mastzellen und basophile Granulozyten. Otorhinolarygol Nova 1991;1:46-52.
11. Bachert C, Ganzer U: Allergische Rhinitis: Zellen und Mediatoren in der Sofort- und Spätphase. 2. Eosinophile Granulozyten und T-Lymphozyten, Makrophagen und Monozyten, neutrophile Granulozyten und epitheliale Zellen. Otorhinolarygol Nova 1991;1:69-74.
12. Rak S, Björenson A, Hakanson L, Sörenson S, Venge P: The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-888.
13. Rak S, Hakanson L, Venge P: Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990;86:706-713.
14. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991;88:27-32.
15. Durham SR, Ying S, Varney VA, Jacobson MR, Kay B, Hamid QA: Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996;97:1356-1365.
16. Hauser U, Bachert C, Frank E: Hemmung des Einstroms von Entzündungszellen in die Nasenschleimhaut durch die allergenspezifische Immuntherapie. Allergo J 1995;4:164-175.
17. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
18. Varney A, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR: Usefullness of immunotherapy in patients with severe summer hayfever uncontrolled by antiallergic drugs. BMJ 1991; 302:265-269.
19. Varney VA, Hamid Q, Gaga M, Sun Ying, Jacobsen M, Frew AJ, Kay AB, Durham SR: Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous response. J Clin Invest 1993;92:644-651.
20. Bachert C: Die Schleimhaut der oberen Atemwege - zur Pathophysiologie der Entzündung. Eur Arch Otorhinolaryngol 1995(suppl I):155-220.
21. Bachert C, Hauser U, Prem B, Rudack C, Ganzer U: Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1995; 252(suppl 1):44-49.
22. Röseler S, Holtappels G, Wagenmann M, Bachert C: Elevated levels of interleukins IL-1β, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1995;252 (suppl 1):61-63.
23. Adams DH, Shaw S: Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994;343:831-836.
24. Collins PD, Weg VB, Faccioli LH, Watson ML, Moqbel R, Williams TJ: Eosinophil accumulation induced by human interleukin 8 in the guinea-pig in vivo. Immunology 1993;79:312-318.
25. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB: Interleukin 8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993;23:1027-1036.
26. Hauser U, Wagenmann M, Rudack C, Bachert C: Unterschiedlicher Antagonismus zwischen IL-1β und seinem Rezeptorantagonisten IL-1Ra bei saisonaler und experimenteller Allergenexposition. Allergologie 1996;19:518.
27. Saloga J, Klimek L, Bellinghausen I, Mann W, Knopp I: Assessment of clinical and immunological changes following specific allergen immunotherapy in patients with allergic rhinitis to birchpollen. Allergo J 1996;5:331-338.
28. Baggiolini M: Novel aspects of inflammation: Interleukin 8 and related chemotactic cytokines. Clin Invest 1993;71:812-814.
29. Shute J: Interleukin 8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994;24: 203-206.
30. Manetti R, Barak V, Piccinni MP, Sampognaro S, Parranchi P, Maggi E, Dinarello C, Romagnani S: Interleukin 1 favors the in-vitro development of type 2 T-helper (Th2) human T-cell clones. Res Immunol 1994;145:93-100.
31. Baroody FM, Lee BJ, Lim MC, Bochner BS: Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol 1995;252(suppl 1):50-58.